重组因子IX Fc用于治疗B型血友病的治疗

Rolf Ljung1, Davide Matino2, Amy D Shapiro3

  • 1Department of Clinical Sciences-Pediatrics, Lund University, Lund, Sweden.

PubMed
概括

延长半衰期的第九因子 (FIX) 替代剂,rFIXFc,通过extravascularly支持血液静止提供有效的血友病B预防. 它的安全性和有效性已经在各种患者群体中得到了很好的证实.

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Recombinant DNA01:09

Recombinant DNA

Overview
94.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K